You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 25, 2024

LARIAM Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Lariam, and what generic alternatives are available?

Lariam is a drug marketed by Roche and is included in one NDA.

The generic ingredient in LARIAM is mefloquine hydrochloride. There are six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the mefloquine hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Lariam

A generic version of LARIAM was approved as mefloquine hydrochloride by BARR on December 29th, 2003.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for LARIAM?
  • What are the global sales for LARIAM?
  • What is Average Wholesale Price for LARIAM?
Summary for LARIAM
Drug patent expirations by year for LARIAM
Recent Clinical Trials for LARIAM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Cancer Institute (NCI)Phase 1
M.D. Anderson Cancer CenterPhase 1
Centre MurazPhase 2/Phase 3

See all LARIAM clinical trials

US Patents and Regulatory Information for LARIAM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roche LARIAM mefloquine hydrochloride TABLET;ORAL 019591-001 May 2, 1989 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.